BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15758699)

  • 21. Best screening tests for prostate cancer.
    Moul JW
    West J Med; 1998 Aug; 169(2):109-10. PubMed ID: 9735692
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostate-specific antigen dynamics and prostate cancer diagnosis.
    Bartoletti R
    Eur Urol; 2009 Nov; 56(5):761-2; discussion 763. PubMed ID: 19665286
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical impact of body mass index on prostate biopsy in patients with intermediate PSA levels].
    Sekita N; Suzuki H; Kamijima S; Chini K; Fujimura M; Mikami K
    Hinyokika Kiyo; 2008 Jul; 54(7):479-83. PubMed ID: 18697492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
    Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
    J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer: screening and early detection.
    Tariman JD
    Adv Nurse Pract; 2006 Sep; 14(9):20. PubMed ID: 16972436
    [No Abstract]   [Full Text] [Related]  

  • 26. Does early detection of prostate cancer offer more good than harm?
    Feightner JW
    Can J Oncol; 1994 Nov; 4 Suppl 1():74-5. PubMed ID: 8853495
    [No Abstract]   [Full Text] [Related]  

  • 27. Can we accurately identify men with low risk prostate cancer?
    Neal DE
    J Urol; 2008 Oct; 180(4):1217-8. PubMed ID: 18707718
    [No Abstract]   [Full Text] [Related]  

  • 28. Extent of prostate-specific antigen contamination in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Luján M; Páez A; Pascual C; Angulo J; Miravalles E; Berenguer A
    Eur Urol; 2006 Dec; 50(6):1234-40; discussion 1239-40. PubMed ID: 16704893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
    Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
    Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of prostate cancer: yes or no?].
    Van Cangh PJ
    Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224
    [No Abstract]   [Full Text] [Related]  

  • 31. [Based on current knowledge the introduction of the PSA screening for prostatic cancer is unethical].
    Krantz I; Sachs L; Ahlberg BM; Nordin P; Nilstun T
    Lakartidningen; 2005 Sep 5-11; 102(36):2498-500. PubMed ID: 16196436
    [No Abstract]   [Full Text] [Related]  

  • 32. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer".
    Ablin RJ; Sartor O; Bennett CL
    Arch Intern Med; 2010 Aug; 170(15):1397-9. PubMed ID: 20696969
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosing prostate cancer - what GPs need to know.
    Frydenberg M; Wijesinha S
    Aust Fam Physician; 2007 May; 36(5):345-7. PubMed ID: 17492070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is prostate cancer screening justified in the Bedouin population?
    Abdallah M; Lazarev I; Ariad S; Mermershtain W
    Onkologie; 2009 May; 32(5):260-2. PubMed ID: 19420972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An educational workshop on the early detection of prostate cancer--a before-after evaluation.
    Steginga SK; Pinnock C; Baade PD; Jackson C; Green A; Preston J; Heathcote P; McAvoy B
    Aust Fam Physician; 2005 Oct; 34(10):889-91. PubMed ID: 16217583
    [No Abstract]   [Full Text] [Related]  

  • 38. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
    Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
    Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for prostate cancer in 2007: the PSA era and its challenges are not over.
    Shariat SF; Karakiewicz PI
    Eur Urol; 2008 Mar; 53(3):457-60. PubMed ID: 18079050
    [No Abstract]   [Full Text] [Related]  

  • 40. Is screening for prostate cancer the current gold standard?--"yes".
    Lange PH
    Eur J Cancer; 1997 Mar; 33(3):354-6. PubMed ID: 9155516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.